Topping up your coffee cup throughout the day could provide some protection against common cancers affecting the mouth, ...

Nivolumab is under clinical development by Bristol-Myers Squibb and currently in Phase II for Oral Cavity (Mouth) Cancer.

Dalnicastobart is under clinical development by Lyvgen Biopharma and currently in Phase I for Solid Tumor. According to GlobalData, Phase I drugs for Solid Tumor have a 69% phase transition success ...

Exposure to secondhand smoke could increase the risk of developing oral cancer by 51 percent for individuals, according to a new meta-analysis of prior cancer studies, published in the journal Tobacco ...

Researchers in Pune, from Rasayani Biologics, have discovered that Bioplatin, a nano-platinum-based oral compound, may ...

Cysts and tumors are both types of lumps commonly found in the body. While some cysts can lead to cancer, these are typically benign. Tumors, however, can be either benign or malignant.

The main goal is to remove tumors, tissue ... you may get a dry mouth. With any cancer treatment, it might take a while before you know how it affects your disease. Stay in touch with your ...

Invikafusp alfa has gained FDA fast track designation for treating TMB-H metastatic colorectal cancer. Invikafusp alfa ...

an oral drug that stops cancer-cell growth, was highly effective in pediatric patients with newly diagnosed infantile fibrosarcoma (IFS) or other solid tumors that have a neurotrophic receptor ...

SABCS invited discussant Harold Burstein, MD, PhD, of the Dana-Farber Cancer ... oral SERDs with a second-line CDK4/6 inhibitor such as abemaciclib "can achieve substantial durations of tumor ...

Poster presentation details are below: Author: Molina et al Title: CID-078, a first-in-class oral cyclin A/B-RxL inhibitor, elicits anti-tumor activity in breast cancer patient-derived xenograft ...